Rhabdomyosarcoma Alveolar - 6 Studies Found

Active, not recruiting : Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
:
  • Neuroblastoma
  • Sarcoma
  • Rhabdomyosarcoma-Embryonal
  • : 2009-06-17
    :
    • Drug: Tumor Purged/CD25 Depleted Lymphocytes
Completed : Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
:
  • Adult Rhabdomyosarcoma
  • Childhood Alveolar Rhabdomyosarcoma

    • : 2010-01-22
    :
    • Biological: Cixutumumab Given

Suspended : Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
:
  • Alveolar Rhabdomyosarcoma
  • Botryoid-Type Embryonal Rhabdomyosarc
    : 2015-10-02
    :
    • Drug: Cyclophosphamide Given I
Completed : Biomarkers in Patients With Advanced Rhabdomyosarcoma
:
  • Adult Rhabdomyosarcoma
  • Childhood Alveolar Rhabdomyosarcoma

    • : 2012-08-15
    : Other: Laboratory Biomarker Analysis Correlative studies
Completed : Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
:
  • Adult Rhabdomyosarcoma
  • Childhood Alveolar Rhabdomyosarcoma

    • : 2010-10-15
    :
    • Biological: Bevacizumab Given

Active, not recruiting : Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
:
  • Carcinoid
  • Neuroendocrine

: 2006-04-13
: Drug: Seneca Valley Virus (biological agent) Dose escalation (starting at 1 × 10^7 vp/kg), IV (in t